Advertisement

Picture Kentro Design Is Key to Your Success Berlin 650x100px

News > All

Please find below news from the Benelux countries (Belgium, Luxembourg and The Netherlands) as well as about organisations from these countries.

Total search results: 1982 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Captain T Cell GmbH. (5/22/24). "Press Release: Captain T Cell Secures Seed Financing Round Totaling € 8.5 Million". Schönefeld/Berlin. 2024-05-22
Pheon Therapeutics Ltd.. (5/21/24). "Press Release: Pheon Therapeutics Announces $120m Series B Financing to Fund Development of Its Differentiated ADC Pipeline". London. 2024-05-21
LabGenius. (5/21/24). "Press Release: LabGenius Raises £35 Million Led by M Ventures to Further Develop Its ML-driven Antibody Discovery Platform and Progress a Pipeline of Assets Towards the Clinic". London. 2024-05-21
Forbion Capital Partners. (5/21/24). "Press Release: Forbion Leads $65 Million Series A Financing of Progentos Therapeutics". Naarden. 2024-05-21
Scion Instruments. (5/21/24). "Press Release: SCION Instruments Has a New CEO". 2024-05-21
iTeos Therapeutics Inc.. (5/10/24). "Press Release: iTeos Therapeutics Announces $120 Million Registered Direct Offering". Watertown, MY & Gosselies. 2024-05-10
Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren. 2024-05-07
Medios AG. (5/6/24). "Press Release: Medios AG – Constantijn van Rietschoten Appointed Executive Board Member for International Markets". Berlin. 2024-05-06
Kurma Partners. (5/2/24). "Press Release: Kurma Partners Announces the Promotion of Hadrien Bouchez to the Position of Partner". Paris. 2024-05-02
General Inception. (4/29/24). "Press Release: General Inception Launches Igniter Europe with the Support of Leading Institutions and Venture Capital Firms". Palo Alto, CA & Lyon. 2024-04-29
Miltenyi Biotec B.V. & Co. KG. (4/29/24). "Press Release: Miltenyi Biotec and MiLaboratories Announce Strategic Partnership to Advance Next-generation Therapies". Bergisch Gladbach & San Francisco, CA. 2024-04-29
Addex Therapeutics S.A.. (4/29/24). "Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study". Geneva. 2024-04-29
CureVac N.V.. (4/24/24). "Press Release: CureVac Appoints Thaminda Ramanayake as New Chief Business Officer". Tübingen & Boston, MA. 2024-04-24
Evotec SE. (4/23/24). "Press Release: Evotec SE Appoints Dr Christian Wojczewski as Chief Executive Officer". Hamburg. 2024-04-23
BioLizard N.V.. (4/18/24). "Press Release: BioLizard Appoints Matthew Hall as Director of Business Development". Lausanne & Ghent. 2024-04-18
Evotec SE. (4/17/24). "Press Release: Evotec Welcomes Aurélie Dalbiez as Chief People Officer". Hamburg. 2024-04-17
Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. 2024-04-17
HealthTech For Care. (4/3/24). "Press Release: HealthTech For Care Launches Its European Patient Observatory to Accelerate Healthcare Equality in Europe". Paris. 2024-04-03
BioGeneration Ventures B.V.. (4/2/24). "Press Release: BGV Appoints Peter Halle, PhD as Venture Partner". Amsterdam. 2024-04-02
BioLizard N.V.. (4/2/24). "Press Release: BioLizard and AbnomX Announce Partnership". Ghent. 2024-04-02
NewAmsterdam Pharma Company N.V.. (4/1/24). "Press Release: NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer". Naarden & Miami, FL. 2024-04-01
OpGen, Inc.. (3/25/24). "Press Release: OpGen Announces Acquisition of Preferred Stock by David Lazar". Rockville, MD. 2024-03-25
TNO. (3/25/24). "Press Release: TNO Launches Peregrion to Boost Market Impact of Its Technology that Accelerates Medicine Development". Leiden. 2024-03-25
Angelini Ventures S.p.A.. (3/21/24). "Press Release: Angelini Ventures Invests into Extended €75.8 Million ($82 Mmillion) Series C Financing Round for Nouscom". Rome. 2024-03-21
Capstan Therapeutics, Inc.. (3/20/24). "Press Release: Capstan Therapeutics Announces $175M Oversubscribed Series B Financing". San Diego, CA. 2024-03-20
BioNTech SE. (3/20/24). "Press Release: BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer". Mainz. 2024-03-20
Engrail Therapeutics, Inc.. (3/19/24). "Press Release: Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies". San Diego, CA. 2024-03-19
Medios AG. (3/18/24). "Press Release: Medios Acquires Dutch Market Leader in Pharmaceutical Compounding Services". Berlin. 2024-03-18
Tubulis GmbH. (3/14/24). "Press Release: Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline". Munich. 2024-03-14
Amolyt Pharma SAS. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA. 2024-03-14
Alithea Genomics S.A.. (3/14/24). "Press Release: Alithea Genomics Closes CHF 2.8 Million in Seed Financing Extension Led by Novalis Biotech". Lausanne. 2024-03-14
ProteoNic Biosciences B.V.. (3/13/23). "Press Release: ProteoNic Announces Partnership with Ginkgo Bioworks and Joins the Ginkgo Technology Network". 2024-03-13
Affimed N.V.. (3/6/24). "Press Release: Affimed Announces 1-for-10 Reverse Stock Split". Mannheim. 2024-03-06
Precirix N.V.. (2/29/24). "Press Release: Tom Plitz Commences Role as Chief Executive Officer of Precirix". Brussels. 2024-02-29
Centogene N.V.. (2/28/24). "Press Release: Centogene Explores Strategic Alternatives". Cambridge, MA, Rostock & Berlin. 2024-02-28
Royal Philips. (28/2/24). "Press Release: Charlotte Hanneman to Succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)". Amsterdam. 2024-02-28
Centogene N.V.. (2/28/24). "Press Release: Centogene Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing". Cambridge, MA, Rostock & Berlin. 2024-02-28
Luxembourg Institute of Health (LIH). (2/27/24). "Press Release: Strategic Partnership Forges Innovation in Luxembourg HealthTech. Luxembourg Institute of Health and Catalpa Ventures Join Forces". 2024-02-27
Miltenyi Biotec B.V. & Co. KG. (2/27/24). "Press Release: Miltenyi Biotec Opens Its First Office in India and Plans to Invest in First of Its Kind Cell and Gene Therapy Center of Excellence". Hyderabad. 2024-02-27
InflaRx N.V.. (2/22/24). "Press Release: InflaRx Appoints Jan Medina as Head of Investor Relations". Jena. 2024-02-22
Earlybird VC Management GmbH & Co KG. (2/14/24). "Press Release: Earlybird Health Closes Fresh Fund of EUR 173m". Berlin & Cologne. 2024-02-14
Candriam. (2/13/24). "Press Release: Candriam Strengthens Thematic Investing Expertise with New Appointments and Announces Leadership Transition". London. 2024-02-13
NewAmsterdam Pharma Company N.V.. (2/13/24). "Press Release: NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants". Naarden & Miami, FL. 2024-02-13
NewAmsterdam Pharma Company N.V.. (2/13/24). "Press Release: NewAmsterdam Pharma Announces Pricing of $175.3 Million Public Offering of Ordinary Shares and Pre-Funded Warrants". Naarden & Miami, FL. 2024-02-13
NLC Ventures Netherlands B.V.. (2/2/24). "Press Release: NLC Health Ventures and BioScience Valuation (BSV) Announce Strategic Collaboration". Amsterdam. 2024-02-02
Enterprise Therapeutics Ltd.. (1/30/24). "Press Release: Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing". Brighton. 2024-01-30
Kadans Science Partner. (1/29/24). "Press Release: Kadans Becomes New Partner for Rheinland-Pfalz Location – Collaboration with Technologiezentrum Mainz". 2024-01-29
InflaRx N.V.. (1/25/24). "Press Release: InflaRx Announces Initiation of Its Commitment Program for GOHIBIC (vilobelimab) to Help Broaden Access for Eligible Patients". Ann Arbor, MI. 2024-01-25
BioLizard N.V.. (1/23/24). "Press Release: BioLizard Opens Office in Switzerland – AI-powered Digital Transformation of Life Sciences at Biopôle in Lausanne". Lausanne & Ghent. 2024-01-23
Disco Pharmaceuticals GmbH. (1/16/24). "Press Release: Disco Pharmaceuticals Launches as the Surfaceome Company with EUR 20 Million in Seed Financing". Cologne & Zurich. 2024-01-16
Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion". 2024-01-09
GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio". 2024-01-09
Calypso Biotech B.V.. (1/8/24). "Press Release: Calypso Enters into Agreement to Be Acquired by Novartis". Amsterdam. 2024-01-08
CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA. 2024-01-05
Qiagen N.V.. (1/4/24). "Press Release: Qiagen to Accelerate Investments into Qiagen Digital Insights Bioinformatics Business". Venlo. 2024-01-04
Full-Life Technologies. (1/4/24). "Press Release: Global Radiotherapeutics Company Full-Life Technologies Announces USD $47.3 Million Series B Financing, Prosperity7 Ventures Jointly Leads the Round". Shanghai, Gembloux & Heidelberg. 2024-01-04
Qiagen N.V.. (1/3/24). "Press Release: Qiagen Expands Business in Middle East with New Regional Headquarters and Major Projects". Venlo, Muscat & Ryadh. 2024-01-03
Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners] CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest eve 2023-12-26
UPM Biomedicals. (12/21/23). "Press Release: UPM Biomedicals Enters into Distribution Agreement with Brinter for GrowInk Bioinks". 2023-12-21
Reig Jofre. (12/20/23). "Press Release: Appointment of Laura Martí as Chief Financial Officer (CFO)". Barcelona. 2023-12-20
CureVac N.V.. (12/19/23). "Press Release: CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE". Tübingen. 2023-12-19
HealthTech For Care. (12/18/23). "Press Release: HealthTech For Care Makes Governance Changes, Appointing Pierre Courteille as Chairman and Sophie Villedieu as Managing Director". Paris. 2023-12-18
Shinobi Therapeutics Inc.. (12/12/23). "Press Release: Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform". San Francisco, CA & Kyoto. 2023-12-12
IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". 2023-12-05
Ion Beam Applications S.A. (IBA). (12/5/23). "Press Release: IBA Signs Research Collaboration Agreement with the University of Kansas Medical Center on FLASH Technology". Louvain-la-Neuve. 2023-12-05
ECBF Management GmbH. (11/21/23). "Press Release: 17 Million Euros for Sustainable Agriculture. ECBF Leads RED Horticulture Series A Financing Round, Together with Demeter IM and Unigrains". Luxembourg. 2023-11-21
Bioxodes S.A.. (11/21/23). "Press Release: Bioxodes Closes €12 Million in Series A Funding Round". Gosselies. 2023-11-21
Da Vinci Labs. (11/20/23). "Press Release: The European ‘SynBee Pitch Competition’ Will Reward Innovative Synthetic Biology Projects at SynBee Day 2024. Da Vinci Labs Is the New Coordinator of the SynBee Project". Reugny. 2023-11-20
Memo Therapeutics AG. (11/16/23). "Press Release: Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer". Schlieren. 2023-11-16
Gilde Healthcare Partners. (11/15/23). "Press Release: Gilde Healthcare Closes New Venture&Growth Fund at €740 Million Hard Cap". Utrecht. 2023-11-15
NMD Pharma A/S. (11/15/23). "Press Release: NMD Pharma Raises €75 Million (~$80 million) in a Series B Financing". Aarhus. 2023-11-15
Nouscom AG. (11/14/23). "Press Release: Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round". Basel. 2023-11-14
ViaNautis Bio Ltd.. (11/13/23). "Press Release: ViaNautis Bio Announces $25 Million Series A Financing to Drive the Next Generation of Genetic Nanomedicines". Cambridge. 2023-11-13
SwiftPharma B.V.. (11/13/23). "Press Release: SwiftPharma and PlantForm Corporation Target Blockbuster Cancer Drug with New Contract Manufacturing Agreement for Plant-made Biosimilars". Ghent & Toronto, ON. 2023-11-13
VectorY Therapeutics B.V.. (11/13/23). "Press Release: VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases". Amsterdam. 2023-11-13
Kynexis B.V.. (11/7/23). "Press Release: Kynexis Launched to Advance Precision Therapeutics for Brain Diseases". Naarden. 2023-11-07
Mainz Biomed N.V.. (10/26/23). "Press Release: Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations". Berkeley, CA & Mainz. 2023-10-26
Immatics N.V.. (10/24/23). "Press Release: Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy". Houston, TX & Tübingen. 2023-10-24
Aiolos Bio, Inc.. (10/24/23). "Press Release: Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody". San Francisco, CA & London. 2023-10-24
BioLizard N.V.. (10/11/23). "Press Release: BioLizard Launches New AI-empowered “BioVerse” Platform to Facilitate Data-driven R&D for Global Life Sciences Community". Ghent. 2023-10-11
Agomab Therapeutics N.V.. (10/10/23). "Press Release: Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline". Ghent. 2023-10-10
LimmaTech Biologics AG. (10/9/23). "Press Release: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections". Schlieren. 2023-10-09
AstronauTx Ltd.. (10/9/23). "Press Release: AstronauTx Closes £48 Million ($61 Million) Series A Financing to Create New Treatments for Alzheimer’s Disease". London. 2023-10-09
Agomab Therapeutics N.V.. (10/5/23). "Press Release: Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts STENOVA Phase 2a Clinical Trial". Ghent. 2023-10-05
EBD Group. (10/4/23). "Press Release: BIO-Europe Set to Break Records in Munich, Germany". Munich. 2023-10-04
Sanofi S.A.. (10/3/23). "Press Release: Sanofi Announces Agreement for Potential First-in-Class Vaccine against Extraintestinal Pathogenic E. coli". Paris. 2023-10-03
PolyPeptide Group AG. (10/2/23). "Press Release: PolyPeptide Secures Revolving Credit Facility". Baar. 2023-10-02
Clade Therapeutics Inc.. (10/2/23). "Press Release: Clade Therapeutics Announces the Acquisition of Gadeta B.V.". Boston, MA. 2023-10-02
CureVac N.V.. (9/28/23). "Press Release: CureVac Reports Progress in Intellectual Property Infringement Case Against BioNTech in Germany". Tübingen & Boston, MA. 2023-09-28
Nagi Bioscience S.A.. (9/28/23). "Press Release: Nagi Bioscience Secures 12.4M CHF Investment with an Oversubscribed Series A Funding Round". Saint-Sulpice. 2023-09-28
Qiagen N.V.. (9/25/23). "Press Release: Qiagen Enhances QIAwave Portfolio with New Eco-friendlier Nucleic Acid Extraction Kits". Venlo. 2023-09-25
Galapagos N.V.. (9/19/23). "Press Release: Galapagos Appoints Simon Sturge to Its Board of Directors". Mechelen. 2023-09-19
ProteoNic B.V.. (9/19/23). "Press Release: NecstGen and ProteoNic Report Development of Improved Viral Vectors through the Application of Premium 2G UNic Technology". Leiden. 2023-09-19
Thermosome GmbH. (9/19/23). "Press Release: Thermosome Establishes High-Profile Clinical Advisory Board". Munich. 2023-09-19
Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. 2023-09-18
Broken String Biosciences Ltd.. (9/18/23). "Press Release: Broken String Biosciences Closes $15M Series A Funding Round". Cambridge. 2023-09-18
Immatics N.V.. (9/11/23). "Press Release: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics". Cambridge, MA & Tübingen. 2023-09-11
Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. 2023-09-11
Mariana Oncology Inc.. (9/7/23). "Press Release: Mariana Oncology Announces $175 Million Series B Financing". Watertown, MA. 2023-09-07
Corteria Pharmaceuticals SAS. (9/7/23). "Press Release: Corteria Pharmaceuticals Announces a €65M ($71M) Financing to Advance Transformational Medicines in Cardiovascular Diseases". Paris. 2023-09-07
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  next pagenext page



Advertisement

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px

» top